Related Experiment Video
Updated: Dec 29, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[CD20-negative diffuse large B-cell lymphoma complicated by rheumatoid arthritis]
Teruhiko Yoshino1, Junya Makiyama1,2, Yoshitaka Imaizumi3
1Department of Hematology, National Hospital Organization Nagasaki Medical Center.
This case study highlights a rare instance of CD20-negative diffuse large B-cell lymphoma (DLBCL) in a patient with rheumatoid arthritis (RA). Identifying unique features of this uncommon CD20-negative DLBCL is crucial for diagnosis and treatment.
Area of Science:
- Oncology
- Immunology
- Rheumatology
Background:
- CD20 antigen is a key marker for B-cell neoplasms, typically highly expressed on neoplastic B lymphocytes.
- Patients with rheumatoid arthritis (RA) face an elevated risk of developing malignant lymphoma, particularly diffuse large B-cell lymphoma (DLBCL).
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway

